Enhancement of SIV infection with soluble receptor molecules
- PMID: 2309120
- DOI: 10.1126/science.2309120
Enhancement of SIV infection with soluble receptor molecules
Abstract
The CD4 receptor on human T cells has been shown to play an integral part in the human immunodeficiency virus type 1 (HIV-1) infection process. Recombinant soluble human CD4 (rCD4) was tested for its ability to inhibit SIVagm, an HIV-like virus that naturally infects African green monkeys, in order to define T cell surface receptors critical for SIVagm infection. The rCD4 was found to enhance SIVagm infection of a human T cell line by as much as 18-fold, whereas HIV-1 infection was blocked by rCD4. Induction of syncytium formation and de novo protein synthesis were observed within the first 24 hours after SIVagm infection, whereas this process took 4 to 6 days in the absence of rCD4. This enhancing effect could be inhibited by monoclonal antibodies directed to rCD4. The enhancing effect could be abrogated with antibodies from naturally infected African green monkeys with inhibitory titers of from 1:2,000 to 1:10,000; these antibodies did not neutralize SIVagm infection in the absence of rCD4. Viral enhancement of SIVagm infection by rCD4 may result from the modulation of the viral membrane through gp120-CD4 binding, thus facilitating secondary events involved in viral fusion and penetration.
Similar articles
-
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.J Virol. 1990 Dec;64(12):6252-6. doi: 10.1128/JVI.64.12.6252-6256.1990. J Virol. 1990. PMID: 1700834 Free PMC article.
-
Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation.AIDS Res Hum Retroviruses. 1992 Dec;8(12):2011-20. doi: 10.1089/aid.1992.8.2011. AIDS Res Hum Retroviruses. 1992. PMID: 1493051
-
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7207-11. doi: 10.1073/pnas.91.15.7207. Proc Natl Acad Sci U S A. 1994. PMID: 7913749 Free PMC article.
-
Human and simian immunodeficiency viruses: virus-receptor interactions.Trends Microbiol. 1993 Dec;1(9):328-33. doi: 10.1016/0966-842x(93)90072-y. Trends Microbiol. 1993. PMID: 8162421 Review.
-
Complement enhancement of HIV infection is mediated by complement receptors.Immunopharmacology. 1993 Mar-Apr;25(2):87-93. doi: 10.1016/0162-3109(93)90012-f. Immunopharmacology. 1993. PMID: 8500986 Review. No abstract available.
Cited by
-
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Viruses. 2012 Dec;4(12):3859-911. doi: 10.3390/v4123859. Viruses. 2012. PMID: 23342377 Free PMC article. Review.
-
Zidovudine after occupational exposure to HIV.BMJ. 1991 Jun 8;302(6789):1349-51. doi: 10.1136/bmj.302.6789.1349. BMJ. 1991. PMID: 2059707 Free PMC article. No abstract available.
-
Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.J Virol. 2000 Jan;74(1):326-33. doi: 10.1128/jvi.74.1.326-333.2000. J Virol. 2000. PMID: 10590121 Free PMC article.
-
Pathogenesis of human immunodeficiency virus infection.Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993. Microbiol Rev. 1993. PMID: 8464405 Free PMC article. Review.
-
Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers.J Virol. 1992 Sep;66(9):5610-4. doi: 10.1128/JVI.66.9.5610-5614.1992. J Virol. 1992. PMID: 1501294 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
